AzTrials
AzTrials

Developmental DyslexiaNCT06937255

Dynamic Assessment of the Risk for Language and Reading Disorders in Monolingual and Multilingual Children

A study testing computerized Dynamic Assessment in people with Developmental Dyslexia and Developmental Language Disorder, run by IRCCS Eugenio Medea at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The project represents the completion of a part of the recently concluded European project MultiMind, in which a computer platform called MuLiMi was developed and validated. The platform hosts screening tests for the identification of the risk of Language and Learning Disorders in preschool and primary school… Read more about this study

Who is it for?
Ages 4 to 9 yearsHealthy volunteers can take part
What is being tested?
computerized Dynamic Assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteItaly
Study dates
3 Apr 2023to Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 9 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • age 4-6 years (Kindergarten) or 7-9 years (Primary school);
  • Attendance at an Italian-language school in Italy or Switzerland/Germany.
  • Additional inclusion criteria for the multilingual group only:
  • (i) At least one parent speaks at least one language other than Italian in the family;
  • (ii) Continuous exposure to the Italian language for at least two years.

Who cannot join

  • Intellectual disability, major psychopathological disorders, exposure to Italian language for less than two years.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Maria Luisa Lorusso, Ph.D contact

031-877592

marialuisa.lorusso@lanostrafamiglia.it

Italy1 site, 1 recruiting
  • IRCCS E. Medea, polo di Bosisio Parini

    Bosisio Parini, LC, 23842

    Maria Luisa Lorusso, Ph.D, 031-877592, marialuisa.lorusso@lanostrafamiglia.it

    Recruiting

Other trials in Italy

About this study

Official title: Validation of Computerized Dynamic Assessment Tasks to Identify the Risk of Developmental Language Disorders (DLD) and Specific Reading Disorder (SRD) in Monolingual and Multilingual Children

The project represents the completion of a part of the recently concluded European project MultiMind, in which a computer platform called MuLiMi was developed and validated. The platform hosts screening tests for the identification of the risk of Language and Learning Disorders in preschool and primary school children, respectively. The aim is to validate the Dynamic Assessment (DA) tests (a first test assessing the capacity to learn new words for preschool children and a second one assessing the capacity to learn a new spelling code for school-age children) in a population of monolingual and bilingual children attending preschool and primary school. The main goal of the study is to complete the validation of the two Dynamic Assessment tests implemented in the MuLiMi platform developed for the MultiMind project.

Read the detailed description

Dynamic Assessment tests are characterized by their emphasis on the learning process activated during the test itself, focusing on measuring the improvement achieved from the beginning to the end of the test rather than the absolute level of performance. They are thus considered measures of the learning potential (in this case, language and spelling) of the assessed subject. This type of testing is used as an integration of static assessment (traditional, aimed at detecting absolute performance level) and has proven particularly useful in the assessment of multilingual children.

However, computerized tests that can also be used remotely are not currently available. For these reasons, it was found particularly useful to include this type of task within the MuLiMi computerized battery. While the other tests hosted on the MuLiMi platform concern specific L1-L2 pairs, DA tests can be applied regardless of the L1 (provided a minimum L2 mastery is present so as to understand the requests) because they assess the capacity to learn new information and are thus rather independent of previous knowledge. This study will provide baseline data for the MuLiMi battery applied to children belonging to any language minority group and thus enable it to be used comprehensively in the future for the purpose of risk assessment of language and learning disorders.

Being tested
computerized Dynamic Assessment
Keywords
Developmental Dyslexia, Developmental Language Disorder, Dynamic Assessment, computerized assessment, multilingual population, children
Medical subject headings
Dyslexia, Language Development Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • computerized Dynamic AssessmentDiagnostic test

    Also called MuLiMi Dynamic Assessment tools

    The DA tests (with a duration of about 30 minutes) can be administered by accessing the digital platform MuLiMi, individually with the experimenter or examiner. The tests are in game form and require children to learn the names of characters presented in the context of stories (preschool version) or to learn new codes for reading and writing (primary school version). In both cases, the new materials (names or codes) are repeatedly presented to the child until (s)he reaches an accuracy threshold. The number of repetitions needed to reach the threshold constitutes the main measure of the child's learning capacity, together with the number of errors committed during the various cycles.

Study groups in NCT06937255
Study groupRoleWhat they receive
TD preschooler, monolingualActive comparatorThis group will include monolingual children who have not been referred to clinical or educational services for any delay or disorder in language abilities. They will be tested with the MuLiMi battery (lexical, phonological and morphosyntactic tests), including the DA Novel Word Learning Test (NWLT) as DA screening test. Furthermore, they will be assessed with standardized language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
TD preschooler, multilingualActive comparatorThis group will include multilingual children who have not been referred to clinical or educational services for any delay or disorder in language abilities. They will be tested with the MuLiMi battery (lexical, phonological and morphosyntactic tests), including the DA Novel Word Learning Test (NWLT) as DA screening test. Furthermore, they will be assessed with standardized language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
DLD preschooler, monolingualExperimentalThis group will include monolingual children who have been referred to clinical or educational services because of delays or disorders in language abilities. They will be tested with the MuLiMi battery (lexical, phonological and morphosyntactic tests), including the DA Novel Word Learning Test (NWLT) as DA screening test. Furthermore, they will be assessed with standardized language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
DLD preschooler, multilingualExperimentalThis group will include multilingual children who have been referred to clinical or educational services because of delays or disorders in language abilities. They will be tested with the MuLiMi battery (lexical, phonological and morphosyntactic tests), including the DA Novel Word Learning Test (NWLT) as DA screening test. Furthermore, they will be assessed with standardized language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
TD school-age, monolingualActive comparatorThis group will include monolingual children who have not been referred to clinical or educational services for any delay or disorder in language abilities. They will be tested with the MuLiMi battery (reading, orthographic and metaphonological tests), including the Dynamic Reading Assessment (DRA) as DA screening test. Furthermore, they will be assessed with standardized reading and language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
TD school-age, multilingualActive comparatorThis group will include monolingual children who have not been referred to clinical or educational services for any delay or disorder in language abilities. They will be tested with the MuLiMi battery (reading, orthographic and metaphonological tests), including the Dynamic Reading Assessment (DRA) as DA screening test. Furthermore, they will be assessed with standardized reading and language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
SRD school-age, monolingualExperimentalThis group will include monolingual children who have been referred to clinical or educational services for any delay or disorder in language abilities. They will be tested with the MuLiMi battery (reading, orthographic and metaphonological tests), including the Dynamic Reading Assessment (DRA) as DA screening test. Furthermore, they will be assessed with standardized reading and language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment
SRD school-age, multilingualExperimentalThis group will include multilingual children who have been referred to clinical or educational services for any delay or disorder in language abilities. They will be tested with the MuLiMi battery (reading, orthographic and metaphonological tests), including the Dynamic Reading Assessment (DRA) as DA screening test. Furthermore, they will be assessed with standardized reading and language tests providing benchmark measures for validation.
Receives: Diagnostic Test: computerized Dynamic Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. accuracy during task performance

    total number and % correct answers, number and % errors during task performance

    Measured: one or two days (one or two consecutive sessions depending on participant's age, collaboration and fatigue)

  2. efficiency during task performance

    number of repeated cycles, number of cycles needed to reach target performance

    Measured: Intervention occurs during assessment: assessment will last one or two days (one or two consecutive sessions depending on participant's age, collaboration and fatigue)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2025
  2. Study start3 Apr 2023
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The study will compare performance in a parallel manner in two populations: preschool and school-age children. Preschool age children will be assessed with the DA screening test for the risk of DLD, whereas school-age children will be assessed with the DA screening test for the risk of SRD. Each of the two groups will be subdivided into 2 groups: typically developing (TD) and atypically developing (AD). Each of the 2 groups will be further subdivided into monolingual and multilingual children. Pairwise comparisons will be performed to assess the capacity of the DA screening tools to discriminate AD from TD children, separately for monolingual and multilingual children.
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06937255
Sponsor's protocol ID
1036
Status last verified
Apr 2025
First submitted
21 Mar 2024
Last updated
4 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • MacLeod AAN, Glaspey AM. Dynamic assessment of multilingual children's word learning. Int J Lang Commun Disord. 2022 Jul;57(4):822-851. doi: 10.1111/1460-6984.12723. Epub 2022 Apr 16.

    PubMed 35429340
  • Orellana CI, Wada R, Gillam RB. The Use of Dynamic Assessment for the Diagnosis of Language Disorders in Bilingual Children: A Meta-Analysis. Am J Speech Lang Pathol. 2019 Aug 9;28(3):1298-1317. doi: 10.1044/2019_AJSLP-18-0202. Epub 2019 Jun 13.

    PubMed 31194570
  • Hunt E, Nang C, Meldrum S, Armstrong E. Can Dynamic Assessment Identify Language Disorder in Multilingual Children? Clinical Applications From a Systematic Review. Lang Speech Hear Serv Sch. 2022 Apr 11;53(2):598-625. doi: 10.1044/2021_LSHSS-21-00094. Epub 2022 Mar 1.

    PubMed 35230888

Questions about this trial

What is this clinical trial studying?

A study testing computerized Dynamic Assessment in people with Developmental Dyslexia and Developmental Language Disorder, run by IRCCS Eugenio Medea at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maria Luisa Lorusso, Ph.D (031-877592, marialuisa.lorusso@lanostrafamiglia.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

accuracy during task performance (time frame: one or two days (one or two consecutive sessions depending on participant's age, collaboration and fatigue)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06937255, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in